Comparing the effect of Melissa officinalis tea versus Matricaria Chamomilla tea on pain intensity, anxiety, and satisfaction with pain management

Comparing the effect of Melissa officinalis tea versus Matricaria Chamomilla tea on pain intensity, anxiety, and satisfaction with pain management in patients undergoing lower limb orthopedic surgury

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170122032101N2

Enrollment

Registered

2018-01-16

Start date

2018-01-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lower limb orthopaedic surgery.

Interventions

Intervention 1: Intervention group: melissa officinalis group: for this group, melissa officinalis tea bag produced by golnoosh darband company will prescribe. each tea bag contains 1g melissa officin

Intervention group: melissa officinalis group: for this group, melissa officinalis tea bag produced by golnoosh darband company will prescribe. each tea bag contains 1g melissa officinalis. melissa of

Intervention group: matricaria chamomilla group: for this group, matricaria chamomilla tea bag produced by golnoosh darband company will prescribe. each tea bag contains 1g matricaria chamomilla. sinc

Control group: or this group, black tea will prescribe at above mentioned times.

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: patient undergoing lower limb orthopaedic surgery willingness to participate in the study normal gag reflex after surgery age 15 and over moderate and sever pain intensity (point 4 and above in VAS scale) orientation to time, place and person no prescription of anxiolytic drug Absence of underlying disease causing pain and anxiety lack of history of sensitivity to Melissa officinalis and Matricaria Chamomilla no prescription of warffarin no prescription benzodiazepines and sedative drugs lack of asthma normal kidney and liver function

Exclusion criteria

Exclusion criteria: pregnant women children

Design outcomes

Primary

Measure	Time frame
Pain intensity score in visual analogue scale. Timepoint: before interventions and 30 minutes after prescribtion of each dose. Method of measurement: visual analogue scale.;Anxiety score in Spielberger state anxiety inventory. Timepoint: before interventions and 30 minutes after prescribtion of each dose. Method of measurement: Spielberger state anxiety inventory.;Satisfaction with pain management score in satisfaction with pain management questionaire. Timepoint: before interventions and 30 minutes after prescribtion of each dose. Method of measurement: satisfaction with pain management questionaire.	—

Measure

Time frame

Pain intensity score in visual analogue scale. Timepoint: before interventions and 30 minutes after prescribtion of each dose. Method of measurement: visual analogue scale.;Anxiety score in Spielberger state anxiety inventory. Timepoint: before interventions and 30 minutes after prescribtion of each dose. Method of measurement: Spielberger state anxiety inventory.;Satisfaction with pain management score in satisfaction with pain management questionaire. Timepoint: before interventions and 30 minutes after prescribtion of each dose. Method of measurement: satisfaction with pain management questionaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza saidi

Shahre-kord University of Medical Sciences

saidi.reza@gmail.com+98 38 3334 6714

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026